Quantitative determination of furosemide in plasma, plasma water, urine and ascites fluid by high-performance liquid chromatography.
A high-performance liquid chromatographic method using spectrofluorometric detection is described for the determination of furosemide in plasma, plasma water, urine and ascites fluid. The extraction procedure decreases interference from endogenous substances. The detection limit of furosemide is 10 ng in 0.5 ml of biological sample. The method is sufficiently sensitive for pharmacokinetic study of furosemide with normal subjects and patients with liver cirrhosis and/or renal disease after oral administration of furosemide in a retard capsule, and for study of protein binding of furosemide in patients with various diseases.
D001202:Ascitic Fluid / Q000378:metabolism*; D001798:Blood Proteins / Q000378:metabolism; D002851:Chromatography, High Pressure Liquid / Q000379:methods; D005665:Furosemide / Q000097:blood* / Q000378:metabolism / Q000652:urine; D006801:Humans; D007674:Kidney Diseases / Q000378:metabolism; D007700:Kinetics; D008103:Liver Cirrhosis / Q000378:metabolism; D013058:Mass Spectrometry / Q000379:methods; D011485:Protein Binding; D013050:Spectrometry, Fluorescence / Q000379:methods
D001798:Blood Proteins; D005665:Furosemide